Drugs / Zolendronic acid
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01472146 | Oct 2011 → Jul 2016 | breast cancer | Susanne Crocamo | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01656512 | Oct 2011 → Jan 2014 | osteoporosis | Children's Cancer Hospital Egypt 57357 | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zolendronic acid | “Drug: zolendronic acid Zolendronic acid 4mg IV every 21 days for 8 cycles combine with chemotherapy” NCT01472146 ↗ |
| Route | Intravenous | “Zolendronic acid 4mg IV every 21 days for 8 cycles combine with chemotherapy” NCT01472146 ↗ |